Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Ally Bridge launches healthcare hedge fund

    Ally Bridge Group launched ABG-LB, a hedge fund of undisclosed size that will invest primarily in healthcare companies headquartered in Greater China that are listed in China or the U.S.Chief Investment Officer Bin Li …

    Published on 7/27/2015
  • FINANCIAL NEWS: Biosimilar play Oncobiologics raises $31M

    Oncobiologics Inc. (Cranbury, N.J.) raised $31 million in a venture round led by Perceptive Advisors. New investors Cormorant Global Healthcare Master Fund; Longwood Capital Partners; and venBio Select Fund also …

    Published on 7/27/2015
  • FINANCIAL NEWS: Financial tracks

    Evercore (NYSE:EVR) hired Edmund Baxter as a senior managing director in its healthcare group. He was a senior managing director and head of west coast life sciences coverage at Bank of America Merrill Lynch.

    Published on 7/27/2015
  • FINANCIAL NEWS: Index raises EUR 60M toward life sciences fund

    Index Ventures has raised EUR 60 million ($66.5 million) toward Index Ventures Life VII, a new fund with an indefinite target size, according to an SEC filing. The firm did not respond to inquiries.In March 2012, the …

    Published on 7/27/2015
  • FINANCIAL NEWS: leon-nanodrugs raises EUR 18.5M in series A

    leon-nanodrugs GmbH (Munich, Germany) raised EUR 18.5 million ($20.5 million) in the first close of a planned EUR 21.5 million ($23.8 million) series A round led by new investor TVM Capital Life Science. New investors …

    Published on 7/27/2015
  • FINANCIAL NEWS: Exelixis raises $135M in follow-on

    Exelixis Inc. raised $135 million through the sale of 25 million shares at $5.40 in a follow-on underwritten by Cowen; William Blair; and Stifel. The company proposed to sell 20 million shares after market on Tuesday, …

    Published on 7/24/2015
  • FINANCIAL NEWS: ADHD company Neos up after $72M IPO

    Neos Therapeutics Inc. (NASDAQ:NEOS) gained $4.54 (30%) to $19.54 in its first day of trading Thursday after raising $72 million through the sale of 4.8 million shares at $15 in an upsized IPO underwritten by UBS; BMO …

    Published on 7/23/2015
  • FINANCIAL NEWS: GenSight gets $36M series B ahead of listing

    Gene therapy developer GenSight Biologics S.A. (Paris, France) raised $36 million in a series B round led by Fidelity. Also participating were new investors Jennison Associates; Sphera Global HealthCare Fund; Perceptive…

    Published on 7/23/2015
  • FINANCIAL NEWS: KalVista raises $33M in series B

    KalVista Pharmaceuticals Ltd. (Salisbury, U.K.) raised $33 million in a series B round led by new investor RA Capital. New investors Longwood Fund and Venrock and existing investors Novo A/S and SV Life Sciences also …

    Published on 7/23/2015
  • FINANCIAL NEWS: MRL, Baupost lead RaNA's $55M B round

    RaNA Therapeutics Inc. (Cambridge, Mass.) raised $55 million in an oversubscribed series B round co-led by MRL Ventures, the venture arm of Merck & Co. Inc. (NYSE:MRK), and The Baupost Group. New investors Rock Springs …

    Published on 7/23/2015
  • FINANCIAL NEWS: SutroVax raises $22M in series A

    SutroVax Inc. (South San Francisco, Calif.) raised $22 million in an oversubscribed series A round led by Abingworth. Longitude Capital; Roche Venture Fund; and CTI Life Sciences also participated. SutroVax was spun out…

    Published on 7/23/2015
  • FINANCIAL NEWS: VCs, crossovers back Ra in $58.5M series B

    Ra Pharmaceuticals Inc. (Cambridge, Mass.) raised $58.5 million in a series B round led by RA Capital; Novo Ventures; and Lightstone Ventures. New investors Rock Springs Capital and Limulus Venture Partners also …

    Published on 7/23/2015
  • FINANCIAL NEWS: Dynavax raises $125M in follow-on

    Dynavax Technologies Corp. (NASDAQ:DVAX) raised $125 million through the sale of 4.5 million shares at $27.50 in a follow-on underwritten by Cowen; RBC Capital Markets; and William Blair. The company proposed the …

    Published on 7/22/2015
  • FINANCIAL NEWS: Sequoia backs MedGenome's $20M series B

    MedGenome Inc. (San Francisco, Calif.) raised $20 million in a series B round from Sequoia Capital. The company operates a next-generation sequencing lab in India, and markets diagnostic tests for cancer and metabolic …

    Published on 7/22/2015
  • FINANCIAL NEWS: Dauntless raises $12M series A

    Asset-centric company Dauntless Pharmaceuticals Inc. (San Diego, Calif.) made its debut on Tuesday with a $12 million series A round from Sofinnova Ventures and a deal with drug delivery company Aegis Therapeutics LLC (…

    Published on 7/21/2015
  • FINANCIAL NEWS: Exact Sciences raises $178.5M in follow-on

    Exact Sciences Corp. (NASDAQ:EXAS) raised $178.5 million through the sale of 7 million shares at $25.50 in a follow-on underwritten by Jefferies and Baird. The company proposed the offering after market close Monday, …

    Published on 7/21/2015
  • FINANCIAL NEWS: Oxford Nanopore raises L70M

    Oxford Nanopore Technologies Ltd. (Oxford, U.K.) raised L70M ($109.2 million) in a private placement with undisclosed new and existing investors in the U.K., U.S. and Europe. The company develops and markets nanopore-…

    Published on 7/21/2015
  • FINANCIAL NEWS: Athyrium, Neuberger close $1.2B fund

    Athyrium Capital Management and partner Neuberger Berman closed a $1.2 billion fund that will invest in commercial stage healthcare companies. The fund, Athyrium Opportunities Fund II, plans to make about 20 investments…

    Published on 7/20/2015
  • FINANCIAL NEWS: Financial tracks

    Investment firm Water Street Healthcare Partners named Paul Cottey chief information officer. Cottey was EVP and CIO at PatientMatters LLC.

    Published on 7/17/2015
  • FINANCIAL NEWS: RedHill, Trovagene price follow-ons

    RedHill Biopharma Ltd. (Tel Aviv:RDHL; NASDAQ:RDHL) raised $40 million on Friday through the sale of 2.5 million ADSs at $16.25 in an offering underwritten by Nomura; Roth Capital Partners; MLV; and H.C. Wainwright. …

    Published on 7/17/2015
  • FINANCIAL NEWS: Shandong Luoxin invests $10M in WuXi fund

    Shandong Luoxin Pharmaceutical Group Stock Co. Ltd. (HKSE:8058) committed to invest $10 million in WuXi Healthcare Ventures Fund II through its Luoxin Hong Kong Holdings Ltd. subsidiary.The WuXi fund plans to raise $250…

    Published on 7/17/2015
  • FINANCIAL NEWS: Chiasma gains after upsized IPO

    Chiasma Inc. (NASDAQ:CHMA) gained $4 (25%) to $20 in its first day of trading Thursday after it raised $101.8 million through the sale of 6.4 million shares at $16 in an IPO underwritten by Barclays; Cowen; William …

    Published on 7/16/2015
  • FINANCIAL NEWS: Follow-ons: Ultragenyx, NeuroDerm, Synthetic Biologics

    Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), NeuroDerm Ltd. (NASDAQ:NDRM) and Synthetic Biologics Inc. (NYSE-M:SYN) raised a combined $370.9 million in follow-on offerings on Thursday.Ultragenyx raised $264 million …

    Published on 7/16/2015
  • FINANCIAL NEWS: Piqur raises CHF18M in series A extension

    Piqur Therapeutics AG (Basel, Switzerland) raised CHF18 million ($19 million) in a second extension of its series A round from new and existing investors. Prior investor Versant Ventures was among the investors; it led …

    Published on 7/16/2015
  • FINANCIAL NEWS: ProNAi rises following $137.7M IPO

    ProNAi Therapeutics Inc. (NASDAQ:DNAI) jumped $13.30 (81%) to $30.80 in its first day of trading Thursday after raising $137.7 million through the sale of 8.1 million shares at $17 in an IPO. The price valued the …

    Published on 7/16/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993